Loading...
The Iterative Development of Medicines Through the European Medicine Agency's Adaptive Pathway Approach
The development of novel regulatory tools such as adaptive clinical trial design and utilization of real-world evidence are topics of high interest. Recently, the European Medicines Agency (EMA) introduced the Adaptive Pathways (AP) that represents an innovative tool in healthcare systems allowing t...
Na minha lista:
| Udgivet i: | Front Med (Lausanne) |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Frontiers Media S.A.
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6610487/ https://ncbi.nlm.nih.gov/pubmed/31316991 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmed.2019.00148 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|